CONMED Corporation (CNMD)
USD 69.32
(-2.68%)
USD 69.32
(-2.68%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 564.24 Million USD | 2.21% |
| 2022 | 501.19 Million USD | 9.35% |
| 2021 | 458.31 Million USD | 10.63% |
| 2020 | 414.29 Million USD | -7.03% |
| 2019 | 445.6 Million USD | 12.01% |
| 2018 | 397.8 Million USD | 3.57% |
| 2017 | 384.1 Million USD | 3.63% |
| 2016 | 370.65 Million USD | 12.14% |
| 2015 | 330.52 Million USD | -4.38% |
| 2014 | 345.68 Million USD | -1.22% |
| 2013 | 349.96 Million USD | 2.74% |
| 2012 | 340.63 Million USD | 11.19% |
| 2011 | 306.35 Million USD | -0.63% |
| 2010 | 308.29 Million USD | -0.25% |
| 2009 | 309.06 Million USD | 0.63% |
| 2008 | 307.12 Million USD | 15.32% |
| 2007 | 266.31 Million USD | -16.11% |
| 2006 | 317.44 Million USD | 27.35% |
| 2005 | 249.27 Million USD | 11.42% |
| 2004 | 223.73 Million USD | 30.2% |
| 2003 | 171.84 Million USD | 8.88% |
| 2002 | 157.82 Million USD | 1.57% |
| 2001 | 155.39 Million USD | -8.07% |
| 2000 | 169.03 Million USD | 16.57% |
| 1999 | 145 Million USD | 12.23% |
| 1998 | 129.2 Million USD | 185.21% |
| 1997 | 45.3 Million USD | 10.49% |
| 1996 | 41 Million USD | 22.75% |
| 1995 | 33.4 Million USD | 22.34% |
| 1994 | 27.3 Million USD | -4.55% |
| 1993 | 28.6 Million USD | 73.33% |
| 1992 | 16.5 Million USD | 17.86% |
| 1991 | 14 Million USD | 19.66% |
| 1990 | 11.7 Million USD | 48.1% |
| 1989 | 7.9 Million USD | 41.07% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 119.69 Million USD | -15.33% |
| 2024 Q3 | 113.28 Million USD | -16.66% |
| 2024 Q2 | 135.94 Million USD | 13.58% |
| 2023 Q3 | 137.75 Million USD | -3.85% |
| 2023 Q4 | 141.35 Million USD | 2.61% |
| 2023 FY | 512.28 Million USD | 2.21% |
| 2023 Q2 | 143.27 Million USD | 0.46% |
| 2023 Q1 | 142.62 Million USD | 7.27% |
| 2022 Q3 | 127.36 Million USD | 0.04% |
| 2022 Q4 | 132.95 Million USD | 4.39% |
| 2022 Q1 | 113.54 Million USD | -4.29% |
| 2022 FY | 501.19 Million USD | 9.35% |
| 2022 Q2 | 127.31 Million USD | 12.13% |
| 2021 Q2 | 115.71 Million USD | 6.78% |
| 2021 Q1 | 108.36 Million USD | -2.21% |
| 2021 Q3 | 115.59 Million USD | -0.11% |
| 2021 Q4 | 118.64 Million USD | 2.63% |
| 2021 FY | 458.31 Million USD | 10.63% |
| 2020 Q4 | 110.81 Million USD | 6.23% |
| 2020 Q3 | 104.31 Million USD | 11.96% |
| 2020 Q2 | 93.17 Million USD | -12.09% |
| 2020 Q1 | 105.98 Million USD | -7.11% |
| 2020 FY | 414.29 Million USD | -7.03% |
| 2019 Q1 | 109.8 Million USD | 2.78% |
| 2019 FY | 445.6 Million USD | 12.01% |
| 2019 Q2 | 112.53 Million USD | 2.49% |
| 2019 Q3 | 109.17 Million USD | -2.99% |
| 2019 Q4 | 114.09 Million USD | 4.51% |
| 2018 FY | 397.8 Million USD | 3.57% |
| 2018 Q2 | 99.58 Million USD | 7.92% |
| 2018 Q1 | 92.27 Million USD | -8.44% |
| 2018 Q4 | 106.83 Million USD | 7.8% |
| 2018 Q3 | 99.1 Million USD | -0.49% |
| 2017 Q3 | 89.07 Million USD | -3.04% |
| 2017 Q1 | 102.37 Million USD | 8.51% |
| 2017 FY | 384.1 Million USD | 3.63% |
| 2017 Q4 | 100.78 Million USD | 13.14% |
| 2017 Q2 | 91.86 Million USD | -10.27% |
| 2016 FY | 370.65 Million USD | 12.14% |
| 2016 Q4 | 94.35 Million USD | 8.0% |
| 2016 Q1 | 94.2 Million USD | 5.36% |
| 2016 Q3 | 87.36 Million USD | -7.79% |
| 2016 Q2 | 94.73 Million USD | 0.57% |
| 2015 FY | 330.52 Million USD | -4.38% |
| 2015 Q3 | 78.7 Million USD | -2.93% |
| 2015 Q4 | 89.4 Million USD | 13.6% |
| 2015 Q2 | 81.08 Million USD | -0.3% |
| 2015 Q1 | 81.32 Million USD | -4.78% |
| 2014 Q1 | 83.92 Million USD | -10.41% |
| 2014 FY | 345.68 Million USD | -1.22% |
| 2014 Q3 | 92.63 Million USD | 10.65% |
| 2014 Q2 | 83.71 Million USD | -0.25% |
| 2014 Q4 | 85.4 Million USD | -7.8% |
| 2013 Q1 | 85.23 Million USD | -5.58% |
| 2013 FY | 349.96 Million USD | 2.74% |
| 2013 Q4 | 93.67 Million USD | 9.96% |
| 2013 Q3 | 85.19 Million USD | -0.78% |
| 2013 Q2 | 85.85 Million USD | 0.73% |
| 2012 FY | 340.63 Million USD | 11.19% |
| 2012 Q3 | 83.79 Million USD | 1.36% |
| 2012 Q2 | 82.67 Million USD | -1.45% |
| 2012 Q1 | 83.88 Million USD | 7.86% |
| 2012 Q4 | 90.27 Million USD | 7.72% |
| 2011 Q4 | 77.77 Million USD | 3.19% |
| 2011 FY | 306.35 Million USD | -0.63% |
| 2011 Q2 | 74.75 Million USD | -4.71% |
| 2011 Q3 | 75.37 Million USD | 0.82% |
| 2011 Q1 | 78.45 Million USD | 1.4% |
| 2010 Q2 | 78.9 Million USD | 0.86% |
| 2010 Q3 | 73.78 Million USD | -6.49% |
| 2010 Q4 | 77.37 Million USD | 4.87% |
| 2010 FY | 308.29 Million USD | -0.25% |
| 2010 Q1 | 78.23 Million USD | -8.12% |
| 2009 Q2 | 72.27 Million USD | 4.74% |
| 2009 FY | 309.06 Million USD | 0.63% |
| 2009 Q4 | 85.14 Million USD | 3.04% |
| 2009 Q3 | 82.63 Million USD | 14.33% |
| 2009 Q1 | 69 Million USD | -8.01% |
| 2008 Q4 | 75.01 Million USD | -2.76% |
| 2008 Q3 | 77.14 Million USD | -1.4% |
| 2008 Q2 | 78.23 Million USD | 1.97% |
| 2008 Q1 | 76.72 Million USD | 6.69% |
| 2008 FY | 307.12 Million USD | 15.32% |
| 2007 Q3 | 65.44 Million USD | -2.28% |
| 2007 Q2 | 66.97 Million USD | 8.05% |
| 2007 FY | 266.31 Million USD | -16.11% |
| 2007 Q4 | 71.91 Million USD | 9.89% |
| 2007 Q1 | 61.98 Million USD | -49.01% |
| 2006 Q4 | 121.55 Million USD | 91.48% |
| 2006 FY | 317.44 Million USD | 27.35% |
| 2006 Q3 | 63.48 Million USD | -4.17% |
| 2006 Q2 | 66.24 Million USD | -0.79% |
| 2006 Q1 | 66.76 Million USD | 0.19% |
| 2005 FY | 249.27 Million USD | 11.42% |
| 2005 Q4 | 66.64 Million USD | 11.38% |
| 2005 Q3 | 59.83 Million USD | -4.34% |
| 2005 Q2 | 62.55 Million USD | 3.76% |
| 2005 Q1 | 60.28 Million USD | -24.33% |
| 2004 Q1 | 48.53 Million USD | 23.5% |
| 2004 Q4 | 79.66 Million USD | 64.96% |
| 2004 Q2 | 47.24 Million USD | -2.65% |
| 2004 Q3 | 48.29 Million USD | 2.22% |
| 2004 FY | 223.73 Million USD | 30.2% |
| 2003 Q2 | 54.95 Million USD | 64.75% |
| 2003 Q4 | 39.29 Million USD | -11.17% |
| 2003 Q1 | 33.35 Million USD | -19.62% |
| 2003 FY | 171.84 Million USD | 8.88% |
| 2003 Q3 | 44.23 Million USD | -19.5% |
| 2002 FY | 157.82 Million USD | 1.57% |
| 2002 Q1 | 38.29 Million USD | -6.48% |
| 2002 Q2 | 39.21 Million USD | 2.42% |
| 2002 Q3 | 38.81 Million USD | -1.03% |
| 2002 Q4 | 41.49 Million USD | 6.91% |
| 2001 Q1 | 40.71 Million USD | -8.81% |
| 2001 FY | 155.39 Million USD | -8.07% |
| 2001 Q4 | 40.94 Million USD | 6.3% |
| 2001 Q3 | 38.52 Million USD | 3.0% |
| 2001 Q2 | 37.39 Million USD | -8.14% |
| 2000 FY | 169.03 Million USD | 16.57% |
| 2000 Q1 | 40.05 Million USD | 6.53% |
| 2000 Q2 | 42.74 Million USD | 6.72% |
| 2000 Q3 | 41.58 Million USD | -2.72% |
| 2000 Q4 | 44.64 Million USD | 7.36% |
| 1999 Q1 | 35.7 Million USD | 3.48% |
| 1999 Q2 | 35.7 Million USD | 0.0% |
| 1999 Q4 | 37.6 Million USD | 4.16% |
| 1999 Q3 | 36.1 Million USD | 1.12% |
| 1999 FY | 145 Million USD | 12.23% |
| 1998 Q3 | 33.5 Million USD | 7.72% |
| 1998 FY | 129.2 Million USD | 185.21% |
| 1998 Q2 | 31.1 Million USD | 3.32% |
| 1998 Q4 | 34.5 Million USD | 2.99% |
| 1998 Q1 | 30.1 Million USD | 166.37% |
| 1997 Q1 | 10.8 Million USD | 9.09% |
| 1997 Q3 | 12.1 Million USD | 8.04% |
| 1997 Q2 | 11.2 Million USD | 3.7% |
| 1997 Q4 | 11.3 Million USD | -6.61% |
| 1997 FY | 45.3 Million USD | 10.49% |
| 1996 Q3 | 10.9 Million USD | 2.83% |
| 1996 Q1 | 9.6 Million USD | 3.23% |
| 1996 Q4 | 9.9 Million USD | -9.17% |
| 1996 FY | 41 Million USD | 22.75% |
| 1996 Q2 | 10.6 Million USD | 10.42% |
| 1995 Q1 | 6.9 Million USD | 0.0% |
| 1995 Q4 | 9.3 Million USD | 16.25% |
| 1995 Q3 | 8 Million USD | -10.11% |
| 1995 FY | 33.4 Million USD | 22.34% |
| 1995 Q2 | 8.9 Million USD | 28.99% |
| 1994 Q1 | 7 Million USD | -42.62% |
| 1994 FY | 27.3 Million USD | -4.55% |
| 1994 Q4 | 6.9 Million USD | 2.99% |
| 1994 Q3 | 6.7 Million USD | -2.9% |
| 1994 Q2 | 6.9 Million USD | -1.43% |
| 1993 Q3 | 7.2 Million USD | 46.94% |
| 1993 Q4 | 12.2 Million USD | 69.44% |
| 1993 FY | 28.6 Million USD | 73.33% |
| 1993 Q1 | 4.8 Million USD | 4.35% |
| 1993 Q2 | 4.9 Million USD | 2.08% |
| 1992 Q2 | 4 Million USD | 11.11% |
| 1992 Q1 | 3.6 Million USD | -7.69% |
| 1992 FY | 16.5 Million USD | 17.86% |
| 1992 Q3 | 5.4 Million USD | 35.0% |
| 1992 Q4 | 4.6 Million USD | -14.81% |
| 1991 FY | 14 Million USD | 19.66% |
| 1991 Q1 | 3.1 Million USD | 3.33% |
| 1991 Q4 | 3.9 Million USD | 11.43% |
| 1991 Q3 | 3.5 Million USD | 0.0% |
| 1991 Q2 | 3.5 Million USD | 12.9% |
| 1990 Q2 | 3 Million USD | 7.14% |
| 1990 FY | 11.7 Million USD | 48.1% |
| 1990 Q4 | 3 Million USD | 3.45% |
| 1990 Q3 | 2.9 Million USD | -3.33% |
| 1990 Q1 | 2.8 Million USD | 16.67% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q4 | 2.4 Million USD | 14.29% |
| 1989 FY | 7.9 Million USD | 41.07% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q3 | 2.1 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Abbott Laboratories | 15.71 Billion USD | 96.409% |
| Allurion Technologies Inc. | 120.57 Million USD | -367.959% |
| Artivion, Inc. | 223.43 Million USD | -152.532% |
| Avanos Medical, Inc. | 375.5 Million USD | -50.264% |
| Butterfly Network, Inc. | 162.46 Million USD | -247.299% |
| Butterfly Network, Inc. | 162.46 Million USD | -247.299% |
| Bio-Rad Laboratories, Inc. | 1.04 Billion USD | 46.137% |
| Boston Scientific Corporation | 7.47 Billion USD | 92.455% |
| Perspective Therapeutics, Inc. | 17.42 Million USD | -3137.932% |
| Edwards Lifesciences Corporation | 3.09 Billion USD | 81.745% |
| Paragon 28, Inc. | 210.1 Million USD | -168.559% |
| Glaukos Corporation | 367.83 Million USD | -53.395% |
| Globus Medical, Inc. | 887.16 Million USD | 36.399% |
| Inspire Medical Systems, Inc. | 568.49 Million USD | 0.748% |
| Integer Holdings Corporation | 250.95 Million USD | -124.834% |
| Medtronic plc | 16.12 Billion USD | 96.502% |
| Nevro Corp. | 389.36 Million USD | -44.912% |
| Owlet, Inc. | 51.21 Million USD | -1001.626% |
| Penumbra, Inc. | 590.87 Million USD | 4.508% |
| Vicarious Surgical Inc. | 80.66 Million USD | -599.479% |
| Smith & Nephew plc | 3.46 Billion USD | 83.725% |
| Sonendo, Inc. | 68.46 Million USD | -724.132% |
| STERIS plc | 1.4 Billion USD | 59.707% |
| Stryker Corporation | 9.2 Billion USD | 93.873% |
| Vapotherm, Inc. | 66.02 Million USD | -754.588% |
| Zimmer Biomet Holdings, Inc. | 3.27 Billion USD | 82.776% |